SEC Form 4 · accession 0001209191-19-012956
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron Cohen
Officer — President and CEO · Director
Period of report
Feb 21, 2019
Accepted (ET)
Feb 25, 2019 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 21, 2019 | F | 2,027 | $13.38 | D | 491,507 | D | |
| Common StockF2 | holding | — | — | — | 120,000 | I | Beneficial Ownership in Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with settlement of restricted stock units that vested as reported on a prior Form 4.
- F2The shares are held in grantor retained annuity trust, which was established by the reporting person and of which he is the sole trustee.